News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
TapImmune Inc. Appoints Dr. Robert Florkiewicz as Senior Director of Molecular Biology & Virology
April 11, 2012
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
SEATTLE, April 11, 2012 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV) has announced that Robert Florkiewicz, Ph.D., has been appointed Senior Director of Molecular Biology & Virology.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
Drug Development
Can Saudi Arabia’s burgeoning biotech hub withstand geopolitical pressures?
November 2, 2026
·
6 min read
·
Jennifer C. Smith-Parker
Earnings
AstraZeneca employs $1.5B cost savings to reinvest back into growth
October 30, 2026
·
3 min read
·
Annalee Armstrong
Earnings
Regeneron achieves ‘clean sweep’ in Q3 with myriad pipeline catalysts on deck
October 30, 2026
·
4 min read
·
Heather McKenzie
Earnings
Sanofi targets late-phase and commercial M&A to offset looming Dupixent decline
October 30, 2026
·
2 min read
·
Nick Paul Taylor
